☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

BMJ debates patient group sponsorship

The current issue of the British Medical Journal debates the sponsorship of patient groups by drug companies in a "Head to Head".

Alastair Kent argues in favour of accepting money from the drug companies stating that not accepting sponsorship will limit the effectiveness of patient groups.

Barbara Mintzes argues against accepting money from the drug companies stating that, in accepting the money, the independence of the patient group is undermined.

The issue of sponsorship will always be a topic for debate. In the meantime, all patient groups should declare full details of sponsorship and provide easy access to this information. This transparent approach would improve confidence in the independence of the patient group and also allow individuals to assess any potential for bias.

Action: Clinicians should consider the transparency and bias of patient groups before implementing any recommendations made by these groups.

Share 'BMJ debates patient group sponsorship' by emailShare 'BMJ debates patient group sponsorship' on FacebookShare 'BMJ debates patient group sponsorship' on TwitterShare 'BMJ debates patient group sponsorship' on MastodonShare 'BMJ debates patient group sponsorship' on LinkedInShare 'BMJ debates patient group sponsorship' on reddit

atomic-wealth

No Comments to “BMJ debates patient group sponsorship”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.